Ετικέτες

Παρασκευή 13 Απριλίου 2018

An epi(c)genetic war: Pathogens, cancer and human genome

Publication date: Available online 13 April 2018
Source:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Author(s): Deepa Rajagopalan, Sudhakar Jha
Cancer is characterized by inter and intra-heterogeneity and this is also observed in the context of cancers caused by pathogens. Nearly 20% of all cancers are attributable to pathogenic organisms. Pathogenic infections result in deregulation of gene expression both by genetic and epigenetic mechanisms, thereby causing malignant transformation. Another characteristic of pathogen-induced cancers is the occurrence of chronic inflammation due to activation of the innate and adaptive arms of the immune system. This review focuses on the epigenetic changes induced by oncoviruses, parasites, cancer-causing bacteria and 'endogenous pathogens' to trigger host cell proliferation indefinitely as well as the inflammation associated with pathogen-induced cancers. The opportunity of targeting components of both pathogen and host epigenetic machinery to limit tumor progression is also discussed.



https://ift.tt/2GYiJ9q

Nervous system and primary liver cancer

Publication date: Available online 13 April 2018
Source:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Author(s): Seogsong Jeong, Bo Zheng, Hongyang Wang, Qiang Xia, Lei Chen
Recent advances have found irregular activities of the nervous system-associated factors in the development and progression of primary liver cancer. These factors contributed in the regulation of migration, proliferation, and apoptosis of cancer cells, and took a role in modulating invasion, metastasis, and recurrence after curative treatment. In clinical researches, neural-related factors were found to be significant prognostic factors, suggesting that the interactions between nervous system and primary liver cancer are indispensable in understanding underlying biological mechanisms. Herein, we reviewed up-to-date achievements in this area and the future perspectives of the interactions between the nervous system and primary liver cancer.

Graphical abstract

image


https://ift.tt/2HzeTor

Protein restriction and cancer

Publication date: April 2018
Source:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Volume 1869, Issue 2
Author(s): Jie Yin, Wenkai Ren, Xingguo Huang, Tiejun Li, Yulong Yin
Protein restriction without malnutrition is currently an effective nutritional intervention known to prevent diseases and promote health span from yeast to human. Recently, low protein diets are reported to be associated with lowered cancer incidence and mortality risk of cancers in human. In murine models, protein restriction inhibits tumor growth via mTOR signaling pathway. IGF-1, amino acid metabolic programing, FGF21, and autophagy may also serve as potential mechanisms of protein restriction mediated cancer prevention. Together, dietary intervention aimed at reducing protein intake can be beneficial and has the potential to be widely adopted and effective in preventing and treating cancers.



https://ift.tt/2GYiGKM

ILT4 functions as a potential checkpoint molecule for tumor immunotherapy

Publication date: April 2018
Source:Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, Volume 1869, Issue 2
Author(s): Aiqin Gao, Yuping Sun, Guangyong Peng
Immune checkpoint blockade therapy targeting CTLA4 and PD-1/PD-L1 is a promising strategy in the treatment of different types of cancers. However, the clinical success rates of these therapies are still moderate and varied among cancer types. Therefore, identification of alternative and novel checkpoint molecules or interrupting tolerogenic pathways is urgently needed for successful tumor immunotherapy. Immunoglobulin-like transcript 4 (ILT4) is as an immunosuppressive molecule predominantly expressed in myeloid cells, including monocytes, macrophages, dendritic cells and granulocytes. Recent studies revealed that ILT4 is also enriched in tumor cells and stroma cells in the tumor microenvironment of various malignancies, modulating the biological behaviors of tumor cells and promoting their immune escape. However, the underlying mechanisms responsible for ILT4-mediated tumor development and progression are still poorly understood. In this review, we explore the functional role of ILT4 as a novel checkpoint molecule in cancers. We specifically discuss the mechanisms mediated by ILT4 for controlling tumor malignant behaviors, impairing effector anti-tumor immune responses, and sustaining the tumor suppressive microenvironment. We also highlight the potential role of ILT4 as a novel immune checkpoint target for tumor immunotherapy. Improved understanding of these issues is critical for elucidation of the role of ILT4 in tumor pathogenesis and should open new avenues for cancer immunotherapy specifically targeting this novel and alternative checkpoint molecule.



https://ift.tt/2HzeN03

Age-related defects in short-term plasticity are reversed by acetyl-L-carnitine at the mouse calyx of Held

elsevier-non-solus.png

Publication date: July 2018
Source:Neurobiology of Aging, Volume 67
Author(s): Mahendra Singh, Pedro Miura, Robert Renden
Hearing acuity and sound localization are affected by aging and may contribute to cognitive dementias. Although loss of sensorineural conduction is well documented to occur with age, little is known regarding short-term synaptic plasticity in central auditory nuclei. Age-related changes in synaptic transmission properties were evaluated at the mouse calyx of Held, a sign-inverting relay synapse in the circuit for sound localization, in juvenile adults (1 month old) and late middle–aged (18–21 months old) mice. Synaptic timing and short-term plasticity were severely disrupted in older mice. Surprisingly, acetyl-l-carnitine (ALCAR), an anti-inflammatory agent that facilitates mitochondrial function, fully reversed synaptic transmission delays and defects in short-term plasticity in aged mice to reflect transmission similar to that seen in juvenile adults. These findings support ALCAR supplementation as an adjuvant to improve short-term plasticity and potentially central nervous system performance in animals compromised by age and/or neurodegenerative disease.



https://ift.tt/2HALJW7

APOE genotype modifies the association between central arterial stiffening and cognition in older adults

elsevier-non-solus.png

Publication date: July 2018
Source:Neurobiology of Aging, Volume 67
Author(s): Francis E. Cambronero, Dandan Liu, Jacquelyn E. Neal, Elizabeth E. Moore, Katherine A. Gifford, James G. Terry, Sangeeta Nair, Kimberly R. Pechman, Katie E. Osborn, Timothy J. Hohman, Susan P. Bell, J. David Sweatt, Thomas J. Wang, Joshua A. Beckman, John Jeffrey Carr, Angela L. Jefferson
Arterial stiffening is associated with cognitive impairment and prodromal Alzheimer's disease. This study tested the interaction between arterial stiffening and an Alzheimer's disease genetic risk factor (apolipoprotein E [APOE] genotype) on cognition among older adults. Vanderbilt Memory & Aging Project participants with normal cognition (n = 162, 72 ± 7 years, 29% APOE-ε4 carrier) and mild cognitive impairment (n = 121, 73 ± 8 years, 42% APOE-ε4 carrier) completed neuropsychological assessment and cardiac MRI to assess aortic stiffening using pulse wave velocity (PWV, m/s). Linear regression models stratified by cognitive diagnosis related aortic PWV × APOE-ε4 status to neuropsychological performances, adjusting for demographic and vascular risk factors. PWV × APOE-ε4 related to poorer performance on measures of lexical retrieval (β = −0.29, p = 0.01), executive function (β = −0.44, p = 0.02), and episodic memory (β = −3.07, p = 0.02). Among participants with higher aortic PWV, APOE-ε4 modified the association between central arterial stiffening and cognition, such that carriers had worse performances than noncarriers. Findings add to a growing body of evidence for APOE-vascular interactions on cognition in older adults and warrant further research into less heart-healthy cohorts where the association between PWV and cognition among older adults might be stronger.



https://ift.tt/2GZ982e

Muscle strength and size are associated with motor unit connectivity in aged mice

elsevier-non-solus.png

Publication date: July 2018
Source:Neurobiology of Aging, Volume 67
Author(s): Kajri A. Sheth, Chitra C. Iyer, Christopher G. Wier, Alexander E. Crum, Anna Bratasz, Stephen J. Kolb, Brian C. Clark, Arthur H.M. Burghes, W. David Arnold
In older adults, the loss of muscle strength (dynapenia) and the loss of muscle mass (sarcopenia) are important contributors to the loss of physical function. We sought to investigate dynapenia, sarcopenia, and the loss of motor unit function in aging mice. C57BL/6J mice were analyzed with cross-sectional (males: 3 vs. 27 months; males and females: 8 vs. 12 vs. 20 months) and longitudinal studies (males: 10–25 months) using in vivo electrophysiological measures of motor unit connectivity (triceps surae compound muscle action potential and motor unit number estimation), in vivo measures of plantar flexion torque, magnetic resonance imaging of hind limb muscle volume, and grip strength. Compound muscle action potential amplitude, motor unit number estimation, and plantar flexion torque were decreased at 20 months. In contrast, grip strength was reduced at 24 months. Motor unit number estimates correlated with muscle torque and hind limb muscle volume. Our results demonstrate that the loss of motor unit connectivity is an early finding in aging male and female mice and that muscle size and contractility are both associated with motor unit number.



https://ift.tt/2HyXtbs

Escitalopram alleviates stress-induced Alzheimer's disease-like tau pathologies and cognitive deficits by reducing hypothalamic-pituitary-adrenal axis reactivity and insulin/GSK-3β signal pathway activity

elsevier-non-solus.png

Publication date: July 2018
Source:Neurobiology of Aging, Volume 67
Author(s): Chao Wu, Wei-Gang Gong, Yan-Juan Wang, Jun-Jun Sun, Hong Zhou, Zhi-Jun Zhang, Qing-Guo Ren
Chronic stress, a causal factor for depression, can also cause cognitive impairments and tau pathology. However, whether and how the selective serotonin reuptake inhibitor antidepressant escitalopram ameliorates these effects are still unclear. In the present study, rats were subjected to chronic mild unpredictable stress for 8 weeks. Following the initial 4 weeks, the stressed animals were separated into susceptible (depressive) and unsusceptible (resistant) groups based on behavioral tests. Then, escitalopram (10 mg/kg i.p.) was administered for 28 days. Pathophysiological changes were assessed by performing behavioral and biochemical analyses. The results showed that both depressive and resistant rats displayed spatial memory deficits and an accumulation of tau in the hippocampus. Increased levels of corticosterone and insulin and a decreased level of glucocorticoid receptor were found in both depressive and resistant rats. We also found that activity-dependent phosphorylated insulin receptor substrate and glycogen synthase kinase-3β (Ser9 site) were significantly decreased in both depressive and resistant rats. However, other important kinases, such as cyclin-dependent kinase 5 and mitogen-activated protein kinase kinase-1/2, did not change in our study. Furthermore, we found that the mRNA expression of tau was increased in depressive and resistant rats. No significant change in LC3B expression was found. Interestingly, almost all the pathological changes in depressive and resistant rats previously mentioned could be reversed by escitalopram. Our results suggested that escitalopram ameliorates cognitive impairments and selectively attenuates phosphorylated tau accumulation in stressed rats through the regulation of hypothalamic-pituitary-adrenal axis activity and the insulin receptor substrate/glycogen synthase kinase-3β signaling pathway.



https://ift.tt/2GZdXIG

Evidence of Wnt/β-catenin alterations in brain and bone of a tauopathy mouse model of Alzheimer's disease

elsevier-non-solus.png

Publication date: July 2018
Source:Neurobiology of Aging, Volume 67
Author(s): Christine M. Dengler-Crish, Hope C. Ball, Li Lin, Kimberly M. Novak, Lisa Noelle Cooper
Low bone mineral density (BMD) is a significant comorbidity in Alzheimer's disease (AD) and may reflect systemic regulatory pathway dysfunction. Low BMD has been identified in several AD mouse models selective for amyloid-β or tau pathology, but these deficits were attributed to diverse mechanisms. In this study, we identified common pathophysiological mechanisms accounting for bone loss and neurodegeneration in the htau mouse, a tauopathy model with an early low BMD phenotype. We investigated the Wnt/β-catenin pathway—a cellular signaling cascade linked to both bone loss and neuropathology. We showed that low BMD persisted in male htau mice aged from 6 to 14 months, remaining significantly lower than tau-null and C57BL/6J controls. Osteogenic gene expression in female and male htau mice was markedly reduced from controls, indicating impaired bone remodeling. In both the bone and brain, htau mice showed alterations in Wnt/β-catenin signaling genes suggestive of increased inhibition of this pathway. These findings implicate dysfunctional Wnt signaling as a potential target for addressing bone loss in AD.



https://ift.tt/2HyXqMO

BmSUC1 is essential for glycometabolism modulation in the silkworm, Bombyx mori

Publication date: Available online 14 April 2018
Source:Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
Author(s): Quan Gan, Xinwei Zhang, Daobo Zhang, Liang Shi, Yue Zhou, Tongtong Sun, Song Jiang, Junshan Gao, Yan Meng
Sucrose is the most commonly transported sugar in plants and is easily assimilated by insects to fulfill the requirement of physiological metabolism. BmSuc1 is a novel animal β-fructofuranosidase (β-FFase, EC 3.2.1.26)-encoding gene that was firstly cloned and identified in silkworm, Bombyx mori. BmSUC1 was presumed to play an important role in the silkworm-mulberry enzymatic adaptation system by effectively hydrolyzing sucrose absorbed from mulberry leaves. However, this has not been proved with direct evidence thus far. In this study, we investigated sucrose hydrolysis activity in the larval midgut of B. mori by inhibition tests and found that sucrase activity mainly stemmed from β-FFase, not α-glucosidase. Next, we performed shRNA-mediated transgenic RNAi to analyze the growth characteristics of silkworm larvae and variations in glycometabolism in vivo in transgenic silkworms. The results showed that in the RNAi-BmSuc1 transgenic line, larval development was delayed, and their body size was markedly reduced. Finally, the activity of several disaccharidases alone in the midgut and the sugar distribution, total sugar and glycogen in the midgut, hemolymph and fat body were then determined and compared. Our results demonstrated that silencing BmSuc1 significantly reduced glucose and apparently activated maltase and trehalase in the midgut. Together with a clear decrease in both glycogen and trehalose in the fat body, we conclude that BmSUC1 acts as an essential sucrase by directly modulating the degree of sucrose hydrolysis in the silkworm larval midgut, and insufficient sugar storage in the fat body may be responsible for larval malnutrition and abnormal petite phenotypes.

Graphical abstract

image


https://ift.tt/2H0cD8A

An improved inventory of polychlorinated biphenyls in China: A case study on PCB-153

Publication date: June 2018
Source:Atmospheric Environment, Volume 183
Author(s): Yue Xu, Chongguo Tian, Xiaoping Wang, Jianmin Ma, Jianhui Tang, Yingjun Chen, Jun Li, Gan Zhang
Emission inventory of pollutants is essential for the environmental fate study and management of the pollutant. To construct a reasonable PCB (polychlorinated biphenyls) inventory in China, this study estimates PCB usage and emission using power generating capacity, installed capacity of power plants and transformer substations, population density and GDP as surrogates. Inventory of representative PCB (PCB-153) with a resolution of 1/4° latitude × 1/4° longitude in China from 1952 to 2005 was generated and assessed as an example. Totally, about 20.3 kt PCBs were applied in China, of which 179 t were PCB-153. By the end of 2005, most of them (56.4%) were emitted into the soil, 2.7% entered the air, and about 20.8% was sealed in storage site or still in service. Historical emissions exhibited increasing trends after 1968, 1984 and 1994, which were mainly associated with usage or disposal processes. Although primary emission has been declined since 2005, the influence of secondary emission from soils, unintentionally produced PCBs (UP-PCB), and reemission from storage sites could be a long-lasting issue in the future. This new emission inventory improves previous PCB emission inventory significantly, which underestimated PCB emission in China considerably.

Graphical abstract

image


https://ift.tt/2HjCewG

Relative impact of short-term emissions controls on gas and particle-phase oxidative potential during the 2015 China Victory Day Parade in Beijing, China

Publication date: June 2018
Source:Atmospheric Environment, Volume 183
Author(s): Wei Huang, Dongqing Fang, Jing Shang, Zhengqiang Li, Yang Zhang, Peng Huo, Zhaoying Liu, James J. Schauer, Yuanxun Zhang
A field observation focusing on reactive oxygen species (ROS) was conducted before, during, and after the 2015 China Victory Day Parade to understand the influence of short-term emissions controls on atmospheric oxidative activity. The hourly average concentrations of PM2.5, SO2, NO, NO2, CO, O3, as well as gas and particle-phase ROS, were measured using a series of online instruments. PM2.5 concentrations during control days were significantly lower than non-control days, which directly lead to the "Parade Blue", yet reductions of most gaseous pollutants except SO2 were not so obvious as PM. Similarly, the control measures also led to a great loss of particle-phase ROS throughout the control period, while the reduction of ROS in gas phase was not obvious until the more stringent measures implemented since September 1. Furthermore, only weak positive correlations were observed among ROS and some other measured species, indicating ROS concentrations were affected by a number of comprehensive factors that single marker could not capture. Meanwhile, meteorological condition and regional transportation were also shown to be the minor factors affecting atmospheric oxidizing capacity. The results of this observation mainly revealed the control measures were conducive to reducing particle-related ROS. However, the reduction of gas-phase ROS activity was less effective given the menu of controls employed for the 2015 China Victory Day Parade. Therefore, short-term emissions controls only aimed to PM reduction and visibility improvement will produce the blue sky but will not equivalently reduce the gas-phase ROS. Supplemental control measures will be needed to further reduce gas-phase ROS concentrations.

Graphical abstract

image


https://ift.tt/2ELlXuW

Characterizing the spatial variability of local and background concentration signals for air pollution at the neighbourhood scale

Publication date: June 2018
Source:Atmospheric Environment, Volume 183
Author(s): Kerolyn K. Shairsingh, Cheol-Heon Jeong, Jonathan M. Wang, Greg J. Evans
Vehicle emissions represent a major source of air pollution in urban districts, producing highly variable concentrations of some pollutants within cities. The main goal of this study was to identify a deconvolving method so as to characterize variability in local, neighbourhood and regional background concentration signals. This method was validated by examining how traffic-related and non-traffic-related sources influenced the different signals.Sampling with a mobile monitoring platform was conducted across the Greater Toronto Area over a seven-day period during summer 2015. This mobile monitoring platform was equipped with instruments for measuring a wide range of pollutants at time resolutions of 1 s (ultrafine particles, black carbon) to 20 s (nitric oxide, nitrogen oxides). The monitored neighbourhoods were selected based on their land use categories (e.g. industrial, commercial, parks and residential areas). The high time-resolution data allowed pollutant concentrations to be separated into signals representing background and local concentrations. The background signals were determined using a spline of minimums; local signals were derived by subtracting the background concentration from the total concentration.Our study showed that temporal scales of 500 s and 2400 s were associated with the neighbourhood and regional background signals respectively. The percent contribution of the pollutant concentration that was attributed to local signals was highest for nitric oxide (NO) (37–95%) and lowest for ultrafine particles (9–58%); the ultrafine particles were predominantly regional (32–87%) in origin on these days. Local concentrations showed stronger associations than total concentrations with traffic intensity in a 100 m buffer (ρ:0.21–0.44). The neighbourhood scale signal also showed stronger associations with industrial facilities than the total concentrations. Given that the signals show stronger associations with different land use suggests that resolving the ambient concentrations differentiates which emission sources drive the variability in each signal. The benefit of this deconvolution method is that it may reduce exposure misclassification when coupled with predictive models.

Graphical abstract

image


https://ift.tt/2qsEU1u

Isoprene emission response to drought and the impact on global atmospheric chemistry

elsevier-non-solus.png

Publication date: June 2018
Source:Atmospheric Environment, Volume 183
Author(s): Xiaoyan Jiang, Alex Guenther, Mark Potosnak, Chris Geron, Roger Seco, Thomas Karl, Saewung Kim, Lianhong Gu, Stephen Pallardy
Biogenic isoprene emissions play a very important role in atmospheric chemistry. These emissions are strongly dependent on various environmental conditions, such as temperature, solar radiation, plant water stress, ambient ozone and CO2 concentrations, and soil moisture. Current biogenic emission models (i.e., Model of Emissions of Gases and Aerosols from Nature, MEGAN) can simulate emission responses to some of the major driving variables, such as short-term variations in temperature and solar radiation, but the other factors are either missing or poorly represented. In this paper, we propose a new modelling approach that considers the physiological effects of drought stress on plant photosynthesis and isoprene emissions for use in the MEGAN3 biogenic emission model. We test the MEGAN3 approach by integrating the algorithm into the existing MEGAN2.1 biogenic emission model framework embedded into the global Community Land Model of the Community Earth System Model (CLM4.5/CESM1.2). Single-point simulations are compared against available field measurements at the Missouri Ozarks AmeriFlux (MOFLUX) field site. The modelling results show that the MEGAN3 approach of using of a photosynthesis parameter (Vcmax) and soil wetness factor (βt) to determine the drought activity factor leads to better simulated isoprene emissions in non-drought and drought periods. The global simulation with the MEGAN3 approach predicts a 17% reduction in global annual isoprene emissions, in comparison to the value predicted using the default CLM4.5/MEGAN2.1 without any drought effect. This reduction leads to changes in surface ozone and oxidants in the areas where the reduction of isoprene emissions is observed. Based on the results presented in this study, we conclude that it is important to simulate the drought-induced response of biogenic isoprene emission accurately in the coupled Earth System model.



https://ift.tt/2vi1aQy

The Association Between Heat Waves and Other Meteorological Parameters and Snakebites: Israel National Study

S07364679.gif

Publication date: Available online 13 April 2018
Source:The Journal of Emergency Medicine
Author(s): Sagi Shashar, Maayan Yitshak-Sade, Roman Sonkin, Victor Novack, Eli Jaffe
BackgroundPublished annual estimates report a global burden of 2.5 million snakebite cases and >100,000 deaths. In Israel, envenomations are the third most frequent cause of poisonings that are of moderate to major clinical severity. Most studies focus on the clinical descriptions of snakebites in tropical climates, and we sought to investigate the association between snakebite frequency and meteorological parameters.ObjectiveWe sought to investigate the seasonality of snakebites and evaluate the association between increasingly common heat waves and other meteorological parameters and snakebite frequency in a semiarid nontropical climate.MethodsWe obtained data for all medical evacuations (2008–2015) because of snakebites in Israel. Climate data included daily 24-hour average temperature (°C) and relative humidity (%). We used a time-stratified case crossover method, in which a conditional logistic regression was applied to estimate the association, and we also stratified our analysis by season and by region.ResultsWe identified 1234 snakebite cases over 8 years, of which most (74.2%) occurred in hot seasons and between 6 pm and 9 pm. The risk of snakebite was positively associated with temperature >23°C (odds ratio [OR] 1.24, 95% confidence interval [CI] 1.01–1.53) and inversely with humidity >40% (OR 0.74, 95% CI 0.57–0.97). We also found an association with heat waves both in cold (OR 1.62, 95% CI 1.01–2.60) and hot seasons (OR 1.50, 95% CI 1.18–1.92).ConclusionsIn a semiarid nontropical climate, we observed an association between an increase in the number of snakebite cases and higher temperatures and lower humidity. Moreover, heat waves increased the frequency of snakebites in both cold and hot seasons.



https://ift.tt/2GVMPyx

Is Transcellular Potassium Shifting With Insulin, Albuterol, or Sodium Bicarbonate in Emergency Department Patients With Hyperkalemia Associated With Recurrent Hyperkalemia After Dialysis?

S07364679.gif

Publication date: Available online 13 April 2018
Source:The Journal of Emergency Medicine
Author(s): Brian E. Driver, Lauren R. Klein, Chaitanya Chittineni, Ellen K. Cales, Nathaniel Scott
BackgroundEmergency department (ED) treatment of hyperkalemia often involves shifting potassium into the intracellular space. There is uncertainty whether transcellular shifting causes insufficient potassium removal during hemodialysis, resulting in a subsequent need for further medical therapy or multiple sessions of hemodialysis.ObjectiveWe sought to determine whether transcellular potassium shifting in ED patients with hyperkalemia who undergo hemodialysis is associated with recurrent hyperkalemia with or without repeat hemodialysis within 24 h.MethodsThis was a retrospective observational study of ED patients with a potassium value > 5.3 mmol/L and ≥1 hemodialysis run. Transcellular shifting medications were defined as albuterol, insulin, and sodium bicarbonate. Primary outcomes were recurrent hyperkalemia with and without repeat hemodialysis within 24 h of the initial dialysis run. Generalized estimating equation models were created for the outcomes using administration of a shifting medication as the primary predictor.ResultsFour hundred seventy-nine encounters were identified. In 238 (50%) encounters, a shifting medication was administered. There were 85 outcomes of recurrent hyperkalemia and 36 outcomes of recurrent hyperkalemia with repeat hemodialysis. After adjustment, administration of shifting medications was not associated with recurrent hyperkalemia (adjusted odds ratio 1.26, 95% confidence interval 0.71–2.23) or recurrent hyperkalemia with repeat dialysis (adjusted odds ratio 1.90, 95% confidence interval 0.80–4.48).ConclusionsAdministration of transcellular shifting medications for hyperkalemia in the ED was not associated with either recurrent hyperkalemia after hemodialysis or the need for a second dialysis session within 24 h. Our findings address the uncertainty regarding transcellular potassium shifting before emergent dialysis and support safe ED administration of medications that shift potassium to the intracellular space.



https://ift.tt/2qAQiYr

Metal enhanced fluorescence (MEF) for biosensors: General approaches and a review of recent developments

Publication date: 15 July 2018
Source:Biosensors and Bioelectronics, Volume 111
Author(s): Yoon Jeong, Yun-Min Kook, Kangwon Lee, Won-Gun Koh
Fluorescence-based biosensor platforms have been intensively investigated not only to increase the sensitivity but also to improve the performance of biosensors. By exploiting metal from the macroscopic down to the nanoscopic surface, various architectures have been devised to manipulate fluorescence signals (enhancement, quenching) within near-optical fields. The interaction of a metallic surface with proximal fluorophores (in the range of 5–90 nm) has beneficial effects on optical properties such as an increased quantum yield, improved photostability and a reduced lifetime of fluorophores. This phenomenon called metal-enhanced fluorescence (MEF) has been extensively used in biosensory applications. However, their applications for biological analysis practically remain challenging in biological microenvironments. Therefore, this review primarily provides a general overview of MEF biosensor systems from the basic mechanism to state-of-the-art biological applications. The review also covers the pros and cons of MEF biosensor as well as discussions about further directions in biological perspectives.



https://ift.tt/2GXTw2S

Real-time quartz crystal microbalance cytosensor based on a signal recovery strategy for in-situ and continuous monitoring of multiple cell membrane glycoproteins

elsevier-non-solus.png

Publication date: 15 July 2018
Source:Biosensors and Bioelectronics, Volume 111
Author(s): Bin Zhou, Yan Hao, Dongping Long, Peihui Yang
A real-time quartz crystal microbalance (QCM) cytosensor based on a signal recovery strategy was first developed for in-situ and continuous monitoring of multiple cell membrane glycoproteins. In this work, gold nanoparticles (AuNPs) were linked with ligands to fabricate ligand-functionalized mass nanoprobes with signal amplification for increasing monitoring sensitivity. The mass nanoprobes bound to cell surface could be eluted with glycine-hydrochloric acid buffer, which led to a quick recovery of resonance frequency. Using the strategy, folate receptors (FR), CD44 molecule and epidermal growth factor receptor (EGFR) on cell membrane as the models were monitored continuously. The quantification result of MDA-MB-231 cells showed a range of linearity of 3.0 × 104 to 1.0 × 106 cells and a detection limit of 5.0 × 103 cells. Furthermore, the multianalyte cytosensor exhibited three sensitive and recoverable frequency shifts during continuous monitoring for in-situ and continuous evaluation of the expression levels of FR, CD44 and EGFR on cell membrane, which exhibited that the average numbers of molecules of FR, CD44 and EGFR per MDA-MB-231 cell were 0.5 × 106, 0.2 × 106 and 1.4 × 105 with the relative standard deviation of 4.8%, 4.5% and 5.1%, respectively. Compared with monolithic multichannel QCM, the multianalyte cytosensor based on a single microbalance could not only exclude acoustic interference but also reduce instrumental cost. This work provided a simple and efficient QCM cytosensor for in-situ and continuous monitoring of multiple cell membrane glycoproteins that offered a new avenue for early diagnosis of cancer.



https://ift.tt/2qwoBzX

Open external circuit for microbial fuel cell sensor to monitor the nitrate in aquatic environment

Publication date: 15 July 2018
Source:Biosensors and Bioelectronics, Volume 111
Author(s): Donglin Wang, Peng Liang, Yong Jiang, Panpan Liu, Bo Miao, Wen Hao, Xia Huang
This study employed an open external circuit, rather than a closed circuit applied in previous studies, to operate an microbial fuel cell (MFC) sensor for real-time nitrate monitoring, and achieved surprisingly greater sensitivity (4.42 ± 0.3–6.66 ± 0.4 mV/(mg/L)) when the nitrate was at a concentration of 10–40 mg/L, compared to that of the MFC sensor with a closed circuit (0.8 ± 0.05–1.6 ± 0.1 mV/(mg/L)). The MFC sensor operated in open circuit (O-MFC sensor) delivered much more stable performance than that operated in closed circuit (C-MFC sensor) when affected by organic matter (NaAc). The sensitivity of O-MFC sensor was twice that of C-MFC sensor at a low background concentration of organic matter. When organic matter reached a high concentration, the sensitivity of O-MFC sensor remained at an acceptable level, while that of C-MFC sensor dropped to almost zero. Challenged by a combined shock of organic matter and nitrate, O-MFC sensor delivered evident electrical signals for nitrate warning, while C-MFC failed. Another novel feature of this study lies in a new mathematical model to examine the bioanode process of nitrate monitoring. It revealed that lower capacitance of the bioanode in O-MFC was the major contributor to the improved sensitivity of the device.

Graphical abstract

image


https://ift.tt/2GUk4lE

Highly stable and regenerative graphene–diamond hybrid electrochemical biosensor for fouling target dopamine detection

Publication date: 15 July 2018
Source:Biosensors and Bioelectronics, Volume 111
Author(s): Qilong Yuan, Ying Liu, Chen Ye, Hongyan Sun, Dan Dai, Qiuping Wei, Guosong Lai, Tianzhun Wu, Aimin Yu, Li Fu, Kuan W.A. Chee, Cheng-Te Lin
Graphene is widely recognized as a promising nanomaterial for the construction of high-performance electrochemical biosensors. However, the lack of strong interfacial forces between graphene and conductive substrates is a bottleneck in the fabrication of highly stable graphene electrodes. In this work, few-layer graphene was directly formed on a high pressure high temperature (HPHT) diamond substrate via sp3-to-sp2 conversion by catalytic thermal treatment and using diamond itself as the carbon source. The hybrid electrode prototype was also highly conductive and had a linear electrochemical response to dopamine in the concentration range of 5 μM – 2 mM, with a low detection limit of 200 nM. After prolonged and repeated exposure to dopamine, electrode fouling was observed which led to sensitivity degradation. Based on the strong interfacial bonding between graphene and HPHT diamond, regeneration of the fouled electrode and full performance recovery would be easily achieved by ultrasonic cleaning. The hybrid electrode is highly robust, and shows potential in its application to the detection of biofouling molecules, food processing and wastewater treatment.

Graphical abstract

image


https://ift.tt/2qtMEiE

AIE-based superwettable microchips for evaporation and aggregation induced fluorescence enhancement biosensing

Publication date: 15 July 2018
Source:Biosensors and Bioelectronics, Volume 111
Author(s): Yanxia Chen, Xuehong Min, Xiqi Zhang, Feilong Zhang, Simeng Lu, Li-Ping Xu, Xiaoding Lou, Fan Xia, Xueji Zhang, Shutao Wang
Superwettable microchips with superhydrophilic microwells on superhydrophobic substrate have attracted increasing attention in fluorescence-based biological and medical diagnostics. However, traditional fluorophores often suffer from the aggregation-caused quenching (ACQ) problem at high concentration or in aggregated state. Here, we developed an AIE-based superwettable microchip by combining the evaporation-induced enrichment of superwettable microchips and the aggregation-induced emission of AIEgens together into one chip. Benefitting from the synergistic effect of the above two mechanisms, the AIE molecules (TPE-Z, a tetraphenylethene salt) were enriched from the diluted solution via evaporation and aggregated within the superhydrophilic microwell and then realized the fluorescence enhancement. Based on the dual enhancement effect of the AIE-based superwettable microchip, microRNA-141 (miR-141) can be detected with excellent reproducibility, sensitivity and specificity. A low detection limit of 1 pM can be achieved with higher signal-to-noise ratio than the traditional fluorescent probes. The proposed AIE-based superwettable microchip will provide a simple fluorescence enhancement biosensing platform for rapid, multiplexed and high-throughput analysis of specific targets in environmental monitoring, food safety, medical diagnosis and related research areas.

Graphical abstract

image


https://ift.tt/2GYkKXp

The Role of Semantic Representations in Verbal Working Memory.

Author: Loaiza, Vanessa M.; Camos, Valerie
DOI: 10.1037/xlm0000475
Publication Date: POST AUTHOR CORRECTIONS, 12 April 2018


https://ift.tt/2HldB2v

The Benefits of Retrieval Practice Depend on Item Difficulty and Intelligence.

Author: Minear, Meredith; Coane, Jennifer H.; Boland, Sarah C.; Cooney, Leah H.; Albat, Marissa
DOI: 10.1037/xlm0000486
Publication Date: POST AUTHOR CORRECTIONS, 12 April 2018


https://ift.tt/2EJREFj

Two Sources of Information in Reconstructing Event Sequence.

Author: Jonker, Tanya R.; MacLeod, Colin M.
DOI: 10.1037/xlm0000498
Publication Date: POST AUTHOR CORRECTIONS, 12 April 2018


https://ift.tt/2EJrQJl

Learning of Pitch and Time Structures in an Artificial Grammar Setting.

Author: Prince, Jon B.; Stevens, Catherine J.; Jones, Mari Riess; Tillmann, Barbara
DOI: 10.1037/xlm0000502
Publication Date: POST AUTHOR CORRECTIONS, 12 April 2018


https://ift.tt/2HjwqTU

The Misinterpretation of Noncanonical Sentences Revisited.

Author: Bader, Markus; Meng, Michael
DOI: 10.1037/xlm0000519
Publication Date: POST AUTHOR CORRECTIONS, 12 April 2018


https://ift.tt/2HhGfll

The Role of Preview Validity in Predictability and Frequency Effects on Eye Movements in Reading.

Author: Staub, Adrian; Goddard, Kirk
DOI: 10.1037/xlm0000561
Publication Date: POST AUTHOR CORRECTIONS, 12 April 2018


https://ift.tt/2vc7rND

Production of Familiar Phrases: Frequency Effects in Native Speakers and Second Language Learners.

Author: Siyanova-Chanturia, Anna; Janssen, Niels
DOI: 10.1037/xlm0000562
Publication Date: POST AUTHOR CORRECTIONS, 12 April 2018


https://ift.tt/2HldyUn

Animal models of endometriosis: Replicating the aetiology and symptoms of the human disorder

Publication date: Available online 6 April 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Ioannis Simitsidellis, Douglas A. Gibson, Philippa T.K. Saunders
Endometriosis is a chronic incurable disorder that affects 1 in 10 women of reproductive age: associated symptoms include chronic pain and infertility. The aetiology of endometriosis remains poorly understood but patients, clinicians and researchers are all in agreement that new non-surgical therapies are urgently needed to reduce the severity of symptoms. Preclinical testing of drugs requires the development and validation of models that recapitulate the key features of the disorder. In this review we describe the best-validated animal models (primate, rodent, xenograft) and their contributions to our understanding of the factors underpinning the development of symptoms. We consider the evidence that these models have provided the platform for identification of new therapeutic interventions and reflect on future directions for research and drug validation.



https://ift.tt/2quyVsb

Animal Models of Endocrine Disruption

Publication date: Available online 6 April 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Heather B. Patisaul, Suzanne E. Fenton, David Aylor
Endocrine disrupting chemicals (EDCs) are compounds that alter the structure and function of the endocrine system and may be contributing to disorders of the reproductive, metabolic, neuroendocrine and other complex systems. Typically, these outcomes cannot be modeled in cell-based or other simple systems necessitating the use of animal testing. Appropriate animal model selection is required to effectively recapitulate the human experience, including relevant dosing and windows of exposure, and ensure translational utility and reproducibility. While classical toxicology heavily relies on inbred rats and mice, and focuses on apical endpoints such as tumor formation or birth defects, EDC researchers have used a greater diversity of species to effectively model more subtle but significant outcomes such as changes in pubertal timing, mammary gland development, and social behaviors. Advances in genomics, neuroimaging and other tools are making a wider range of animal models more widely available to EDC researchers.



https://ift.tt/2GYhf3d

Diagnosis and management of hyperthyroidism from prenatal life to adolescence

Publication date: Available online 5 April 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Juliane Léger, Jean Claude Carel
Hyperthyroidism in children is a rare heterogeneous syndrome characterized by excessive thyroid hormone production. Its manifestations differ according to disease severity. For all forms of hyperthyroidism, treatment aims to restore a euthyroid state, enabling the child to demonstrate appropriate metabolism, growth, and neurocognitive development. Graves' disease is the most frequent cause of hyperthyroidism in children. Treatment modalities include antithyroid drugs, with the advantage that prolonged treatment for several years can be followed by freedom from medical intervention in about 40-50% of cases. It may also be treated with radioactive iodine or, less frequently, thyroidectomy, these more radical treatments both necessitating subsequent lifelong levothyroxine treatment. Particular care is required in the management of pregnant women with Graves' disease. Fetal and neonatal forms of hyperthyroidism are transient and rare, but nevertheless serious. Here, we provide an overview of the best approach to hyperthyroidism diagnosis and management, from fetal development to adolescence.



https://ift.tt/2quyXjN

Diagnosis and management of postnatal fetal growth restriction

Publication date: Available online 5 April 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Eloïse Giabicani, Aurélie Pham, Frédéric Brioude, Delphine Mitanchez, Irène Netchine
Fetal growth restriction (FGR) can result from multiple causes, such as genetic, epigenetic, environment, hormonal regulation, or vascular troubles and their potential interaction. The physiopathology of FGR is not yet fully elucidated, but the insulin-like growth factor system is known to play a central role. Specific clinical features can lead to the identification of genetic syndromes in some patients. FGR leads to multiple global health concerns, from the perinatal period, with higher morbidity/mortality, through infancy, with neurodevelopmental, growth, and metabolic issues, to the onset of puberty and later in life, with subfertility and elevated risks of cardiovascular and kidney diseases. Adequate follow-up and therapeutics should be offered to these patients. We first review the main molecular etiologies leading to FGR and their specificities. We then highlight the main issues that FGR can raise later in life before concluding with the proposed management of these children.



https://ift.tt/2GXKJ1b

Translational Studies Provide Insights for the Etiology and Treatment of Cortical Bone Osteoporosis

Publication date: Available online 3 April 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Robert Brommage, Claes Ohlsson
Increasing attention is being focused on the important contributions of cortical bone to bone strength, fractures and osteoporosis therapies. Recent progress in human genome wide association studies in combination with high-throughput mouse gene knock out phenotyping efforts of multiple genes and advanced conditional gene inactivation in mouse models have successfully identified genes with crucial roles in cortical bone homeostasis. Particular attention in this review is given to genes, such as WNT16, POSTN and SFRP4, that differentially affect cortical and trabecular bone architecture. We propose that animal models of cortical bone metabolism will substantially contribute to developing anabolic osteoporosis therapies that improve cortical bone mass and reduce non-vertebral fracture risk.



https://ift.tt/2qwuuNd

Imaging endocrinology in animal models of endocrine disease

Publication date: Available online 3 April 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Patrice Mollard, Marie Schaeffer
Endocrine organs secrete a variety of hormones involved in the regulation of a multitude of body functions. Although pancreatic islets were discovered at the turn of the 19th century, other endocrine glands remained commonly described as diffuse endocrine systems. Over the last two decades, development of new imaging techniques and genetically-modified animals with cell-specific fluorescent tags or specific hormone deficiencies have enabled in vivo imaging of endocrine organs and revealed intricate endocrine cell network structures and plasticity. Overall, these new tools have revolutionized our understanding of endocrine function. The overarching aim of this Review is to describe the current mechanistic understanding that has emerged from imaging studies of endocrine cell network structure/function relationships in animal models, with a particular emphasis on the pituitary gland and the endocrine pancreas.



https://ift.tt/2qwksvT

Vitamin D and calcium in the human breast milk

elsevier-non-solus.png

Publication date: January 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism, Volume 32, Issue 1
Author(s): Yoon Ju Bae, Juergen Kratzsch
Vitamin D and calcium in the human milk is essential for the growth and the prevention of rickets in infants. In this review, we will discuss the physiology and the functions of vitamin D and calcium and the mechanisms of vitamin D and calcium transfer into the human breast milk. This review describes the recommended intake of vitamin D and calcium for infants and lactating mothers and the factors influencing the content of vitamin D and calcium in human milk. Furthermore, the measurement of vitamin D compounds and calcium in human breast milk is described in this review.



https://ift.tt/2GXK7IV

Genetically modified mouse models to investigate thyroid development, function and growth

Publication date: Available online 3 April 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): C. Löf, K. Patyra, A. Kero, J. Kero
The thyroid gland produces thyroid hormones (TH), which are essential regulators for growth, development and metabolism. The thyroid is mainly controlled by the thyroid-stimulating hormone (TSH) that binds to its receptor (TSHR) on thyrocytes and mediates its action via different G protein-mediated signaling pathways. TSH primarily activates the Gs-pathway, and at higher concentrations also the Gq/11-pathway, leading to an increase of intracellular cAMP and Ca2+, respectively. To date, the physiological importance of other G protein-mediated signaling pathways in thyrocytes is unclear. Congenital hypothyroidism (CH) is defined as the lack of TH at birth. In familial cases, high-throughput sequencing methods have facilitated the identification of novel mutations. Nevertheless, the precise etiology of CH yet remains unraveled in a proportion of cases. Genetically modified mouse models can reveal new pathophysiological mechanisms of thyroid diseases. Here, we will present an overview of genetic mouse models for thyroid diseases, which have provided crucial insights into thyroid gland development, function, and growth with a special focus on TSHR and microRNA signaling.



https://ift.tt/2qxwCV1

Mouse models of peripheral metabolic disease

Publication date: Available online 31 March 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Gabriela da Silva Xavier, David J. Hodson
Metabolic disease risk is driven by defects in the function of cells that regulate energy homeostasis, as well as altered communication between the different tissues or organs that these cells occupy. Thus, it is desirable to use model organisms to understand the contribution of different cells, tissues and organs to metabolism. Mice are widely used for metabolic research, since well-characterised mouse strains (in terms of their genotype and phenotype) allow comparative studies and human disease modelling. Such research involves strains containing spontaneous mutations that lead to obesity and diabetes, surgically- and chemically-induced models, those that are secondary to caloric excess, genetic mutants created by transgenesis and gene knockout technologies, and peripheral models generated by Cre-Lox or CRISPR/Cas9 approaches. Focussing on obesity and type 2 diabetes as relevant metabolic diseases, we systematically review each of these models, discussing their use, limitations, and future potential.



https://ift.tt/2GXJY8l

Mouse Models for the Analysis of Gonadotropin Secretion and Action

Publication date: Available online 31 March 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Sara Babcock Gilbert, Allyson K. Roof, T. Rajendra Kumar
Gonadotropins are pituitary gonadotrope-derived glycoprotein hormones. They act by binding to G-protein coupled receptors on gonads. Gonadotropins play critical roles in reproduction by regulating both gametogenesis and steroidogenesis. Although biochemical and physiological studies provided a wealth of knowledge, gene manipulation techniques using novel mouse models gave new insights into gonadotropin synthesis, secretion and action. Both gain of function and loss of function mouse models for understanding gonadotropin action in a whole animal context have already been generated. Moreover, recent studies on gonadotropin actions in non-gonadal tissues challenged the central dogma of classical gonadotropin actions in gonads and revealed new signaling pathways in these non-gonadal tissues. In this Chapter, we have discussed our current understanding of gonadotropin synthesis, secretion and action using a variety of genetically engineered mouse models.



https://ift.tt/2qwNBaa

Evidence from animal models on the pathogenesis of PCOS

Publication date: Available online 31 March 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): K.A. Walters, M.J. Bertoldo, D.J. Handelsman
Polycystic ovarian syndrome (PCOS) is the most common endocrine condition in women, and is characterized by reproductive, endocrine and metabolic features. However, there is no simple unequivocal diagnostic test for PCOS, its etiology remains unknown and there is no cure. Hence, the management of PCOS is suboptimal as it relies on the ad hoc empirical management of its symptoms only. Decisive studies are required to unravel the origins of PCOS, but due to ethical and logistical reasons these are not possible in humans. Experimental animal models for PCOS have been established which have enhanced our understanding of the mechanisms underlying PCOS and propose novel mechanism-based therapies to treat the condition. This review examines the findings from various animal models to reveal the current knowledge of the mechanisms underpinning the development of PCOS, and also provides insights into the implications from these studies for improved clinical management of this disorder.



https://ift.tt/2GWNH5Z

Preface

elsevier-non-solus.png

Publication date: Available online 27 March 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Anna Spada




https://ift.tt/2qybXQC

Thyrotropin receptor, still much to be learned from the patients

elsevier-non-solus.png

Publication date: Available online 22 March 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Dr. Claire Briet, Valentine Suteau-Courant, Mathilde Munier, Prof. Patrice Rodien
In the absence of crystal available for the full-length thyrotropin receptor, knowledge of its structure and functioning has benefitted from the identification and characterization of mutations in patients with various thyroid dysfunctions. The characterization of activating mutations has contributed to the elaboration of a model involving the extracellular domain of the receptor as an inverse tethered agonist which, upon binding of the ligand, relieves the transmembrane domain from an inhibiting interaction and activates it. The models derived from comparisons with other receptors, enriched with the information provided by the study of mutations, have proven useful for the design of small-molecule agonists and antagonists that may be used in the future to treat thyroid dysfunctions. In this review, extrathyroidal expression of the thyrotropin receptor is described, the role of which is still poorly defined.



https://ift.tt/2GXayyf

An orphan G protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations

elsevier-non-solus.png

Publication date: Available online 17 March 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Giampaolo Trivellin, Laura C. Hernández-Ramírez, Jeremy Swan, Constantine A. Stratakis
X-linked acrogigantism (X-LAG) is a recently described form of familial or sporadic pituitary gigantism characterized by very early onset GH and IGF-1 excess, accelerated growth velocity, gigantism and/or acromegaloid features. Germline or somatic microduplications of the Xq26.3 chromosomal region, invariably involving the GPR101 gene, constitute the genetic defect leading to X-LAG. GPR101 encodes a class A G protein-coupled receptor that activates the 3′,5′-cyclic adenosine monophosphate signaling pathway. Highly expressed in the central nervous system, the main physiological function and ligand of GPR101 remain unknown, but it seems to play a role in the normal development of the GHRH-GH axis. Early recognition of X-LAG cases is imperative because these patients require clinical management that differs from that of other patients with acromegaly or gigantism. Medical treatment with pegvisomant seems to be the best approach, since X-LAG tumors are resistant to the treatment with somatostatin analogues and dopamine agonists; surgical cure requires near-total hypophysectomy. Currently, the efforts of our research focus on the identification of GPR101 ligands; in addition, the long-term follow-up of X-LAG patients is of extreme interest as this is expected to lead to better understanding of GPR101 effects on human pathophysiology.



https://ift.tt/2quyRZt

Adipokines in human breast milk

elsevier-non-solus.png

Publication date: January 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism, Volume 32, Issue 1
Author(s): Juergen Kratzsch, Yoon Ju Bae, Wieland Kiess
The review describes the molecular characteristics of so far detected breast milk adipokines and ranks their breast milk level compared to the respective levels in maternal and infant blood. Moreover, analytical knowledge for measurements of breast milk adipokines will be delineated. Next, we summarized data about two main potential influencing factors on adipokine concentration in breast milk, maternal weight and pasteurization of milk. Finally, associations between adipokines in breast milk and weight gain in infants as well as the putative mechanisms for effects of breast milk adipokines on food intake and weight gain in later life will debated. Our findings suggest that a source of adipokines in human breast milk cannot be uniformly defined. In dependence on the ratio between serum and breast milk levels the major quantity of these proteins may be derived from peripheral tissues, from the breast tissue itself or from both. Thus, leptin and in part adiponectin levels in breast milk are dependent on a plenty of influencing factors with an important relevance of maternal anthropometric characteristics There is some evidence that leptin, adiponectin and ghrelin levels in breast milk may be associated with growth gain of infants and even with increased risk for being overweight during infancy or childhood. We hypothesize that a dysregulation in adipokine homeostasis in early life could promote obesity and metabolic disturbance in later life.



https://ift.tt/2H0uHDx

G-protein coupled receptors (GPCRs) in the treatment of diabetes: Current view and future perspectives

elsevier-non-solus.png

Publication date: Available online 15 March 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Guido Sebastiani, Elena Ceccarelli, Maria Grazia Castagna, Francesco Dotta
G-protein coupled receptors (GPCRs) represent the largest receptor family in the genome and are of great interest for the design of novel drugs in a wide variety of diseases including neurologic disorders, obesity and Type 2 diabetes mellitus. The latter is a chronic disease characterized by insulin resistance and impaired insulin secretion, affecting >400 million patients worldwide.Here we provide an overview on: a) The molecular basis of GPCR signalling and of its involvement in the regulation of insulin secretion and of glucose homeostasis; b) the role of GPCRs in type 2 diabetes pathophysiology and as therapeutic targets of current and future glucose-lowering drugs.



https://ift.tt/2qwouV0

Cytokines in milk and the role of TGF-beta

elsevier-non-solus.png

Publication date: January 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism, Volume 32, Issue 1
Author(s): Julia Brenmoehl, Daniela Ohde, Elisa Wirthgen, Andreas Hoeflich
Cytokines are required for normal growth and development of the mammary gland and TGF-β prominently represents an established effector of apoptosis, e.g., during involution of the mammary gland. By the control of intracellular signaling pathways, including JAK/STAT, MAPK, PI-3K, and NF-κB, cytokines efficiently regulate cell proliferation and inflammation in the breast. Therefore, cytokines are discussed also in a context of malignant mammary growth. As a group of tissue hormones produced by somatic cells or by cells from the immune system, cytokines are defined by their immunomodulatory potential. Over the past 40 years, multiple cytokines were identified in colostrum and milk. Importantly, cytokines derived from mammary secretions after birth are required for maturation of the immune system in the developing gastrointestinal tract from the suckling. Moreover, recent studies have further assessed the particular interactions between probiotic bacterial strains and cytokines. In light of the increasing prevalence of inflammatory diseases of the gastrointestinal system, the effects of probiotic microorganisms during milk fermentation may have immunotherapeutic potential in the future.



https://ift.tt/2H0LuGs

Novel mechanisms of GPCR functions: AT1 angiotensin receptor acts as a signaling hub and focal point of receptor cross-talk

Publication date: Available online 15 March 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): András D. Tóth, Gábor Turu, László Hunyady, András Balla
AT1 angiotensin receptor (AT1R), a prototypical G protein-coupled receptor (GPCR), is the main receptor, which mediates the effects of the renin-angiotensin system (RAS). AT1R plays a crucial role in the regulation of blood pressure and salt-water homeostasis, and in the development of pathological conditions, such as hypertension, heart failure, cardiovascular remodeling, renal fibrosis, inflammation, and metabolic disorders. Stimulation of AT1R leads to pleiotropic signal transduction pathways generating arrays of complex cellular responses. Growing amount of evidence shows that AT1R is a versatile GPCR, which has multiple unique faces with distinct conformations and signaling properties providing new opportunities for functionally selective pharmacological targeting of the receptor. Biased ligands of AT1R have been developed to selectively activate the β-arrestin pathway, which may have therapeutic benefits compared to the conventional angiotensin converting enzyme inhibitors and angiotensin receptor blockers. In this review, we provide a summary about the most recent findings and novel aspects of the AT1R function, signaling, regulation, dimerization or oligomerization and its cross-talk with other receptors, including epidermal growth factor (EGF) receptor, adrenergic receptors and CB1 cannabinoid receptor. Better understanding of the mechanisms and structural aspects of AT1R activation and cross-talk can lead to the development of novel type of drugs for the treatment of cardiovascular and other diseases.



https://ift.tt/2qv3gXv

Translational studies provide insights for the etiology and treatment of cortical bone osteoporosis

elsevier-non-solus.png

Publication date: Available online 27 February 2018
Source:Best Practice & Research Clinical Endocrinology & Metabolism
Author(s): Robert Brommage, Claes Ohlsson
Increasing attention is being focused on the important contributions of cortical bone to bone strength, fractures and osteoporosis therapies. Recent progress in human genome wide association studies in combination with high-throughput mouse gene knockout phenotyping efforts of multiple genes and advanced conditional gene inactivation in mouse models have successfully identified genes with crucial roles in cortical bone homeostasis. Particular attention in this review is given to genes, such as WNT16, POSTN and SFRP4, that differentially affect cortical and trabecular bone architecture. We propose that animal models of cortical bone metabolism will substantially contribute to developing anabolic osteoporosis therapies that improve cortical bone mass and reduce non-vertebral fracture risk.



https://ift.tt/2GWtn4E

The 2017 Sachs Lecture: Kindling Knowledge in Epilepsy

S08878994.gif

Publication date: Available online 9 April 2018
Source:Pediatric Neurology
Author(s): Solomon L. Moshé




https://ift.tt/2vcORVA

Health-Related Quality of Life for Genetically Determined Leukoencephalopathy Patients

S08878994.gif

Publication date: Available online 9 April 2018
Source:Pediatric Neurology
Author(s): Amytice Mirchi, Félixe Pelletier, Luan T. Tran, Stephanie Keller, Nancy Braverman, Davide Tonduti, Adeline Vanderver, Federico Roncarolo, Amy Pizzino, Marie-Emmanuelle Dilenge, Chantal Poulin, Michael Shevell, Annette Majnemer, Guillaume Sébire, Myriam Srour, Bradley Osterman, Renée-Myriam Boucher, Michel Vanasse, Elsa Rossignol, John Mitchell, Sunita Venkateswaran, Daniela Pohl, Marcelo Kauffman, Raphael Schiffmann, Cyril Goizet, Sebastien Moutton, Geneviève Bernard
AIMSTo characterize health-related quality of life (HRQOL) in patients with genetically determined leukoencephalopathies as it relates to the severity of clinical features and the presence/absence of a precise molecular diagnosis.METHODHRQOL was assessed using the Pediatric Quality of Life Inventory (PedsQL) model (Pediatric Quality of Life Inventory 4.0 Self and Proxy-reports) on 59 patients diagnosed with genetically determined leukoencephalopathies. In total, 38 male and 21 female patients aged from 1 to 32 years (mean 9 years), as well as their parents, completed the PedsQL HRQOL measures. In addition, participants underwent/filled detailed standardized clinical assessments/questionnaires. The correlation between HRQOL results and the severity of the clinical features as well as the presence/absence of a molecular diagnosis was analyzed.RESULTSPatients with more severe clinical features showed statistically significant lower total PedsQL scores. More specifically, lower HRQOL was noted in children with sialorrhea, wheelchair use, gastrostomy and dystonia.INTERPRETATIONIn this study, we have shown that patients with more severe clinical features experience a lower quality of life. Our study further highlights the importance of addressing both physical and psychosocial issues and discussing perception of quality of life with both parents and children. A future larger multicenter prospective study will be important to further define the burden of these diseases and identify modifiable factors.



https://ift.tt/2qx9iaM

Response to the Letter by Sora Yasri

alertIcon.gif

Publication date: April 2018
Source:Pediatric Neurology, Volume 81
Author(s): Sarah B. Mulkey, Gilbert Vezina, Dorothy I. Bulas, Zarir Khademian, Anna Blask, Youssef Kousa, Caitlin Cristante, Lindsay Pesacreta, Adre J. du Plessis, Roberta L. DeBiasi




https://ift.tt/2vd3WWV

Systemic Lupus Erythematosus Presenting with Severe Optic Disc Edema

alertIcon.gif

Publication date: Available online 4 April 2018
Source:Pediatric Neurology
Author(s): Shashank Shekhar, Hardik Sonani, Jagdish Desai, Riddhiben Patel




https://ift.tt/2vaOFpR

Diffusion-Weighted Imaging Changes in a Child with Posterior Ischemic Optic Neuropathy

S08878994.gif

Publication date: Available online 4 April 2018
Source:Pediatric Neurology
Author(s): Dana B. Harrar, Jessica Solomon, Ankoor S. Shah, Jennifer Vaughn, Adam D. Durbin, Michael J. Rivkin
IntroductionPosterior ischemic optic neuropathy (PION) results from ischemia of the retrobulbar aspect of the optic nerve. It presents as acute loss of vision without optic disc swelling. This is rare in children, with only seven cases reported to date. Neuroimaging is frequently used to aid in the diagnosis of acute visual complaints in children; however, none of the cases described to date delineate the neuroimaging findings of this entity in children.Case ReportWe describe the MRI findings in a 10-month-old boy with PION after intra-ophthalmic artery injection of chemotherapy for retinoblastoma.DiscussionAs targeted therapies for retinoblastoma and other diseases amenable to intravascular treatment delivery are more frequently used, the risk of grave vision-related side effects increases. PION should be considered in the differential diagnosis of any child presenting with acute loss of vision. Dedicated imaging of the orbits can elucidate specific findings that may aid in the diagnosis of this entity in children.



https://ift.tt/2qwZb5V

Maturational Changes of Gamma-Aminobutyric Acid A Receptors Measured With Benzodiazepine Binding of Iodine 123 Iomazenil Single-Photon Emission Computed Tomography

S08878994.gif

Publication date: Available online 3 April 2018
Source:Pediatric Neurology
Author(s): Satoru Ikemoto, Shin-ichiro Hamano, Yuko Hirata, Ryuki Matsuura, Kenjiro Kikuchi
BackgroundIodine 123 (I-123) iomazenil is a specific ligand of the central benzodiazepine receptor, which is a part of the postsynaptic gamma-aminobutyric acid A receptor complex. We performed statistical image processing of I-123 iomazenil single-photon emission computed tomography to elucidate maturational changes in the GABAergic system.MethodsThirty patients (18 boys and 12 girls, aged 17 days to 14 years) with cryptogenic focal epilepsy were enrolled and underwent I-123 iomazenil single-photon emission computed tomography. We used a semiquantitative analytical method consisting of brain surface extraction, anatomic normalization, and a three-parameter exponential model. We then assessed developmental changes in benzodiazepine receptor binding activity in 18 regions of interest in both hemispheres.ResultsThe highest benzodiazepine receptor binding activity was observed during early infancy in all regions of interest. Benzodiazepine receptor binding activity then decreased exponentially across development. Benzodiazepine receptor binding in the primary sensorimotor cortex, primary visual cortex, cerebellar vermis, and striatum declined more rapidly than that in the cerebellar hemispheres and the frontal cortex. The pons and the thalamus had the lowest benzodiazepine receptor binding activities during the neonatal period, and benzodiazepine receptor binding in these areas declined gradually after infancy toward adolescence. There were no differences in adjusted benzodiazepine receptor binding activity according to laterality or sex.ConclusionsBenzodiazepine receptor binding activity decreased exponentially during infancy in all regions of interest. Binding activity in the primary somatosensory and motor cortices (M1 and S1), the primary and association visual areas, the cerebellar vermis, and the striatum (caudate nucleus and putamen) tended to decline more rapidly than that in the cerebellar hemisphere and the frontal association cortex.



https://ift.tt/2HnXjWS

Cerebral Autoregulation and Conventional and Diffusion Tensor Imaging Magnetic Resonance Imaging in Neonatal Hypoxic-Ischemic Encephalopathy

S08878994.gif

Publication date: Available online 2 April 2018
Source:Pediatric Neurology
Author(s): Melisa Carrasco, Jamie Perin, Jacky M. Jennings, Charlamaine Parkinson, Maureen M. Gilmore, Raul Chavez-Valdez, An N. Massaro, Raymond C. Koehler, Frances J. Northington, Aylin Tekes, Jennifer K. Lee
BackgroundDeviation of mean arterial blood pressure (MAP) from the range that optimizes cerebral autoregulatory vasoreactivity (optimal MAP) could increase neurological injury from hypoxic-ischemic encephalopathy (HIE). We tested whether a global magnetic resonance imaging (MRI) brain injury score and regional diffusion tensor imaging (DTI) are associated with optimal MAP in neonates with HIE.MethodsTwenty-five neonates cooled for HIE were monitored with the hemoglobin volume index. In this observational study, we identified optimal MAP and measured brain injury by qualitative and quantitative MRIs with the Neonatal Research Network (NRN) score and DTI mean diffusivity scalars. Optimal MAP and blood pressure were compared with brain injury.ResultsNeonates with blood pressure within optimal MAP during rewarming had less brain injury by NRN score (P = 0.040). Longer duration of MAP within optimal MAP during hypothermia correlated with higher mean diffusivity in the anterior centrum semiovale (P = 0.008) and pons (P = 0.002). Blood pressure deviation below optimal MAP was associated with lower mean diffusivity in cerebellar white matter (P = 0.033). Higher optimal MAP values related to lower mean diffusivity in the basal ganglia (P = 0.021), the thalamus (P = 0.006), the posterior limb of the internal capsule (P = 0.018), the posterior centrum semiovale (P = 0.035), and the cerebellar white matter (P = 0.008). Optimal MAP values were not associated with the NRN score.ConclusionsThe NRN score and the regional mean diffusivity scalars detected injury with mean arterial blood pressure deviations from the optimal MAP. Higher optimal MAP and lower mean diffusivity may be related because of cytotoxic edema and limited vasodilatory reserve at low MAP in injured brain. DTI detected injury with elevated optimal MAP better than the NRN score.



https://ift.tt/2vaOaft

Editorial Board and Masthead

alertIcon.gif

Publication date: April 2018
Source:Pediatric Neurology, Volume 81





https://ift.tt/2EJGT5Q

Combined Chemoradiation Versus Radiation Therapy Alone in stage-II Nasopharyngeal Carcinoma: A Meta-analysis of the published literature

Publication date: Available online 3 April 2018
Source:Current Problems in Cancer
Author(s): Sufang Wang, Shan Li, Liangfang Shen
ObjectiveThe aim of this meta-analysis was to evaluate the efficacy and toxicity of adding chemotherapy to radiotherapy (RT) in the treatment of stage-II nasopharyngeal carcinoma (NPC).Materials and methodsWe searched Pubmed, Cochrane Library, Embase, China National Knowledge Internet, China Biology Medicine, VIP and Wanfang database for studies of the radiotherapy with or without chemotherapy in patients with stage-II NPC that were published in any language. Analyses were carried out using RevMan 5.3 software. The relative risk was used to evaluate the data, the I2 test was used to compare heterogeneity, sensitivity analysis was used to evaluate the stability and reliability of the results.ResultsThere were 16 studies with 3,038 patients that were included in this analysis. Risk ratios (RR) of 1.04 (95% CI 1.01–1.06), 1.05 (95% CI 1.00–1.10), 1.05 (95% CI 1.02–1.07), and 1.00 (95% CI 0.97–1.03) were observed for overall survival (OS), progression-free survival (PFS), loco-regional failure-free survival (LRFS) and distant metastasis failure-free survival (DMFS). Subgroup analysis showed that compared with conventional RT alone, chemoradiation (CRT) could significantly improve OS (RR = 1.09 95% CI 1.03–1.15), PFS (RR = 1.20 95% CI 1.08–1.35), and LRFS (RR = 1.09, 95% CI 1.04–1.14), but did not significantly improve the rate of DMFS (RR = 1.03, 95% CI 0.94–1.12). However, compared with Intensity Modulated Radiation Therapy (IMRT) alone, CRT did not significantly improve the rate of OS (RR = 1.01 95% CI 0.99–1.03), PFS (RR = 0.99 95% CI 0.95–1.03), LRFS (RR = 1.02, 95% CI 0.99–1.05), and DMFS (RR = 0.99, 95% CI 0.96–1.01).ConclusionsCompared with conventional RT alone, CRT could significantly improve patients′ prognoses in terms of OS, PFS, and LRFS for stage-II NPC, but not DMFS, and CRT can provide greater benefits from concurrent chemotherapy than neoadjuvant chemotherapy. With IMRT, the stage-II NPC patients did not benefit from the addition of chemotherapy.



https://ift.tt/2GZDcuH

Bifocal hepatocellular carcinoma (HCC): Magnetic resonance imaging features after trans-arterial embolization (TAE)

Publication date: Available online 28 March 2018
Source:Current Problems in Cancer
Author(s): Picchia Simona, Bali Maria Antonietta




https://ift.tt/2HzlEqb

Influence of wellness-education on first-line icotinib hydrochloride patients with stage IV non-small cell lung cancer and their family caregivers

S01470272.gif

Publication date: Available online 11 April 2018
Source:Current Problems in Cancer
Author(s): Li Yanwei, Fang minghui, Quan manman, Yan zhuchun, Liu dongying, Pan zhanyu
ObjectiveThis study aims to examine the effects of wellness-education (WE) intervention on the behavioral change, psychological status, performance status on patients with stage IV non-small cell lung cancer (NSCLC) undergoing icotinib hydrochloride treatment and their relationships with family caregivers.MethodsWe conducted an intervention study involving 126 individuals with confirmed activating epidermal growth factor receptor (EGFR) mutation-positive stage IV NSCLC who received Icotinib hydrochloride as first-line therapy between 01/2014 and 01/2016; their caregivers were also included in the study. For a period of 12 weeks, participants were randomly assigned into WE and control groups. The patients and family members in the WE group were provided with WE information about treatment, diet, social needs, rehabilitation, physical/mental health education, communication strategies, and patient care advice at least 3 times per week during treatment. Qualitative feedback of the participants was recorded during the intervention. Food Composition Database, the Family Environment Scale (FES) , patients/caregivers quality-of-life [Functional Assessment of Cancer Therapy–Lung (FACT-L)/Caregiver Quality of Life Index-Cancer Scale (CQOLC)], and Hospital Anxiety and Depression Scale (HADS) were measured at baseline and for 12 weeks. Data were analyzed to compare the different outcomes.ResultsOf the 126 caregivers (64 WE and 62 control), 120 completed the study. We observed significant differences between the WE group and control group with respect to low daily calorie intake (31.0% vs. 77.4%, p<0.05), smoking cessationaaa and awareness of cancer (85.48% vs. 100%, p<0.05). The WE group showed high ratings on awareness of cancer risk and benefit, as well as confidence relating to the behaviors of healthful diet and self-motivation to conduct cancer test. Family caregivers had high ratings on 30-min daily moderate physical activity (p>0.05). After 12 weeks, WE intervention had improved scores on FACT-L-EWB and CQOLC adaptation. In addition, the patients also showed improvements in HADS.ConclusionWE interventions in patients with stage IV NSCLC undergoing icotinib hydrochloride treatment and their family resulted in strong intentions to engage in health-promoting behaviors related to physical activity, Smoking cessationaaa and nutrition at the treatment period. WE intervention is a viable way to improve quality of life and HADS.Practice ImplicationsFindings from this study suggests that WE interventions in patients' family with stage IV NSCLC undergoing icotinib hydrochloride treatment are significant improvements in both HADS and QoL. These data also indicate that lung cancer disparities are unlikely to be associated with differential willingness to receive care but that Chinese may perceive financial and insurance ebarriers to treatment



https://ift.tt/2HwjQOF

A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma

elsevier-non-solus.png

Publication date: Available online 21 February 2018
Source:Current Problems in Cancer
Author(s): Yue Wang, Mu Xu, Qing Yang
Uterine corpus endometrial carcinoma (UCEC) is one of the most common female gynecological malignant tumors that threaten women health seriously. MicroRNAs (miRNAs) has been proved to play critical roles in tumor pathogenesis and malignant progression. In this study, we aimed to explore a novel signature of microRNA expression for predicting the overall survival (OS) of patients with UCEC. The genome-wide miRNA expression profiles and relevant clinical characteristics of 348 patients with UCEC were downloaded from the Cancer Genome Atlas (TCGA) data portal and analyzed comprehensively. A total of 144 miRNAs were confirmed to be expressed differentially in tumor tissues. Among them, 6 miRNAs (hsa-mir-15a.MIMAT0000068, hsa-mir-142.MIMAT0000433, hsa-mir-142.MIMAT0000434, hsa-mir-3170.MIMAT0015045, hsa-mir-1976.MIMAT0009451, and hsa-mir-146a.MIMAT0000449) were validated to be significantly correlated with the OS of patients with UCEC. The risk indictor established by the 6-microRNA signature was proved be an independent prognostic factor (Hazard ratio = 0.391; 95% CI: 0.195-0.783; P = 0.008). In conclusion, we identified miRNAs that were correlated with the occurrence and progression of UCEC and established a 6-microRNA expression signature as a predictor for the OS of patients with UCEC.



https://ift.tt/2GWoO6o

The challenge of treating older patients with pancreaticobiliary malignancies

elsevier-non-solus.png

Publication date: January–February 2018
Source:Current Problems in Cancer, Volume 42, Issue 1
Author(s): Lynda R. Corrigan, Dara M. Bracken-Clarke, Anne M. Horgan
Pancreatic and biliary tract cancers are aggressive malignancies. They commonly present with metastatic or unresectable disease. Those that do present with resectable cancer have high rates of recurrence. Despite recent advances in surgical technique, chemotherapy, and radiotherapy regimens, they are associated with poor survival outcomes. These cancers represent an exception to the trend of improved overall survival evident in most malignancies in recent decades. Depending on the goal of treatment, active management of pancreatic and biliary cancers involves surgery, chemotherapy, and radiation therapy, either alone or in combination. Both pancreatic and biliary tract cancers have a preponderance in the older population. Older patients are a heterogeneous group; although tolerability of multimodality treatment may be a challenge for some, many fit older patients may be undertreated based on their age alone. The growing field of geriatric oncology has highlighted the importance of a comprehensive assessment of these patients, and not relying on age alone as a discriminating factor for treatment. Management of older patients with pancreaticobiliary cancers is particularly challenging owing to limited prospective data in this population. As such, there is uncertainty with regard to optimal treatment approaches for these patients. In this article, we outline the therapeutic options available to patients with localized or advanced pancreatic and biliary tract cancers, and the evidence for specified treatment options in the elderly. We examine the inclusion and outcomes of elderly patients in relevant clinical trials; the morbidity that may be encountered by elderly patients receiving specified treatments and the tools that may assist the physician in selecting elderly patients for particular treatments.



https://ift.tt/2GVsvZV

Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcoma

elsevier-non-solus.png

Publication date: Available online 31 January 2018
Source:Current Problems in Cancer
Author(s): Serkan Akin, Omer Dizdar, Yusuf Karakas, Alev Turker, Ayse Kars
Leiomyosarcomas (LMS) are rare tumors with poor prognosis owing to the high rate of recurrent and metastatic disease. The combination of doxorubicin (Adriamycin) plus ifosfamide and mesna (AIM) results in moderate response rates of 10%-30%. The aim of this study was to assess the efficacy of the AIM regimen along with multimodality treatment including surgery and radiotherapy in patients with LMS. The clinicopathologic characteristics and outcomes of 51 patients with recurrent or metastatic LMS diagnosed between 2000 and 2014 who received the AIM regimen were analyzed retrospectively. Treatment consisted of ifosfamide 2500mg/m² on days 1-3 (with mesna 2500mg/m² days 1-3, 4-hour i.v. infusion), and doxorubicin 60mg/m² on day 1 (2-hour i.v. infusion), which was repeated every 21 days. The mean age of the patients at diagnosis was 48.9 ± 11.2 years. A total of 42 patients were females (82.4%). The primary tumor site was the uterus in 30 (58.8%) patients. The most common metastatic sites were lung and liver. The median follow-up was 27.9 months (min: 4.3 max: 164.8). The median progression-free survival was 6.7 months (95% CI: 4.1-9.2). The median overall survival (OS) was 24.6 months (95% CI: 16.2-33.0). The overall response rate was 12% (6/51 pts). Response rates were higher in patients with uterine LMS (17%) compared with those with nonuterine LMS (5%); however, the OS times were similar. Surgical intervention for local or distant recurrence was associated with improved median OS (41 vs 16.6 months, P < 0.001). Myelosuppression was the major toxicity of this combination. In our study, the AIM regimen was effective in patients with LMS. Resection of local or distant recurrence was found to improve survival in our study.



https://ift.tt/2HAYb8k

Cancer cervix: Establishing an evidence-based strategy, an experience of a tertiary care centre in India

elsevier-non-solus.png

Publication date: Available online 12 January 2018
Source:Current Problems in Cancer
Author(s): Shyam Kishore Shrivastava, Shirley Lewis, Supriya Chopra Sastri, G. Lavanya, Umesh Mahantshetty, Reena Engineer
Carcinoma cervix is a common cancer among Indian women. Evidence based management is essential for best practice in treatment of carcinoma cervix for its effective control. The current imaging system like CT, MRI and PET CT scans have contributed in identifying the patients for optimal treatment and delivering treatment accurately. For stages IB2 to IV, concurrent chemoradiation is advocated with improvement in overall survival proven with randomized trials. Brachytherapy is an integral part in the radiation treatment. Imaged-guided brachytherapy using MRI is desirable, however less expensive imaging modalities such as CT and ultrasonography has been evaluated. In special situation such as for HIV positive patients and patients with neuroendocrine tumors have role of radiotherapy. For further improvement in control of cancer, it is required to integrate basic research to answer clinically relevant questions.



https://ift.tt/2GXiUlf

Research of falls risk of taking central nervous system drugs in oncology inpatients

Publication date: Available online 12 January 2018
Source:Current Problems in Cancer
Author(s): Yadi Li, Qing Zhang, Xuhong Yang, Lijun Zheng, Jun Yang, Huan Zhao, Dongdong Yang
This study aimed to analyze the medication use and related falls risk of central nervous system(CNS) drugs in oncology inpatients, explore the association between CNS drugs and falls. In this study, we enrolled inpatients, hospitalized in the oncology department of the Teaching Hospital of Chengdu University of Traditional Chinese Medicine, from March 2013 to October 2015. All inpatients were divided into two groups: taking-CNS drugs group (treatment group) and non CNS drugs group (control group). The falls risk between two groups were being compared and analyzed. Results showed that a total of 768 inpatients were enrolled in this study; 401 of them were males and 367 were females; the average age was 47.9±5.8 year-old. Of them, 129 were taking CNS drugs, while 639 were not. In the treatment group, the number of fall patients was 39, at an incidence rate of 30.23%; of the 39 fall patients, 3 suffered fractures, and 1 suffered an intracranialhemorrhage; while in the control group, the incidence of falls totaled at 45, at an incidence rate of 7.04%; 4 of the patients suffered fractures. The difference of incidence rate between two groups had statistical significance (P< 0.01). The incidence rate of falls in the treatment group was 4.29 times that in the control group. By the further analysis of CNS drugs, results implied that hypnotics, sedatives, selective serotonin reuptake inhibitors (no patient taking tricyclic antidepressants in this study), opioids, antiepileptics and antipsychotics had relationship with falls (OR>1). Our finding indicates that oncology inpatients have a higher risk of falls resulting from taking CNS drugs. Therefore, it is necessary to build up a systemic mechanism of nursing safety management on preventing falls of oncology inpatients, to improve nursing quality, and reduce the risk of falls.



https://ift.tt/2HA68uq

Information for Readers

Publication date: January–February 2018
Source:Current Problems in Cancer, Volume 42, Issue 1





https://ift.tt/2GYUmsp

Management of cervical premalignant lesions

elsevier-non-solus.png

Publication date: Available online 11 January 2018
Source:Current Problems in Cancer
Author(s): Partha Basu, Katayoun Taghavi, Shang-Ying Hu, Sushma Mogri, Smita Joshi
Treatment of cervical premalignant lesions (cervical intraepithelial neoplasia; CIN) of different grades is very effective, simple, and safe. The entire transformation zone of the cervix needs to be treated either by an ablative technique (cryotherapy or thermal ablation) or an excisional technique (large loop excision of transformation zone or cold knife conization); the choice of treatment depends on the size and location of the lesion and the type of the transformation zone. The cure rate after ablative treatment of high-grade CIN may be little lower than that after excisional treatment. The simplicity of the technique, low complication rate, and lesser cost make ablative technique the treatment of choice in the low resourced settings for the eligible lesions. In situations where organizing colposcopy and histopathology services is challenging, simple algorithms like screening with visual inspection with acetic acid test and immediate ablative treatment of the visual inspection with acetic acid-positive women has been recommended by the World Health Organization. Such a strategy is effective in preventing subsequent development of high-grade CIN and also ensures high compliance of the screen positive women to treatment.



https://ift.tt/2HymWSt

A brief report of plexiform neurofibroma

elsevier-non-solus.png

Publication date: Available online 10 January 2018
Source:Current Problems in Cancer
Author(s): Mahdi Khajavi(MD), Shahrokh Khoshsirat(MD), Lida Ahangarnazari(MD), Niloofar Majdinasab(MD)
Plexiform neurofibroma (PNF) is a rare variant of neurofibromatosis type1 (NF-1), which histopathologically, is a subtype of benign nerve sheath tumors, neurofibromas (NF). It develops as a result of proliferation in all parts of peripheral nervous system and can cause the functional damage, deformities, pain, considerable mortality, and morbidity and even the increasing risk of malignant transformation in some critical cases. Currently, the surgical intervention is the treatment of choice for PNF patients, which due to the tumor invasion, massive growth, and the chance of postoperative regrowth is not possible. The diagnosis of isolated tumor is an uncommon event. Considering the rarity of this neoplasm, herein, we describe a case of isolated PNF, so the purpose of this presenting is the rarity of recording. We describe a case of isolated plexiform neurofibroma presented with 7-year history of a slowly growing postauricular soft subcutaneous mass in a 14-year-old boy, which caused the right auricular deformity. After initial evaluation by imaging studies, the patient underwent to surgical resection of the mass and the diagnosis of plexiform neurofibroma was confirmed by histopathologic examination. Surgical excision of the mass had been done before which concluded the satisfactory result and based on oncologist diagnosis, further intervention such as radiotherapy or chemotherapy was not needed. The patient left the hospital with a clinical stability and was suggested to continue the regular follow-up. In conclusion, considering neurofibroma (NF) as differential diagnosis for subcutaneous masses in head and neck area is critical for early diagnosis and treatment procedure.



https://ift.tt/2GYDUbr

The importance of quality-of-life management in patients with advanced pancreatic ductal adenocarcinoma

elsevier-non-solus.png

Publication date: January–February 2018
Source:Current Problems in Cancer, Volume 42, Issue 1
Author(s): Alexandra R. Lewis, Rille Pihlak, Mairéad G. McNamara
Pancreatic ductal adenocarcinoma (PDAC) carries a poor prognosis, and as such, a focus on quality of life is vital. This review will discuss various aspects of quality of life in patients with PDAC and their treatment. Pancreatic exocrine and endocrine insufficiency may result in issues related to nutrition, and pain and fatigue are other common symptoms, and may be managed with pharmaceutical or nonpharmaceutical methods. It has also been reported that low mood is a particular problem for patients with PDAC compared to patients with other cancers; however, the data supporting this is inconsistent. Data regarding improvements in quality of life in patients with PDAC receiving chemotherapy is also reviewed, which in some cases suggests a benefit to chemotherapy, particularly in the presence of a radiological response. Furthermore, the importance of early palliative care is discussed and the benefits reported including improved quality of life and mood, reduced aggressive interventions at the end of life and improved survival. Areas for future development may include increased use of quality of life as a trial outcome and the use of patient-reported outcomes to improve symptomatic care of patients, and particularly in those receiving active systemic treatment.



https://ift.tt/2HA2WyC

Engineering Human Bone Marrow Proxies

Publication date: 1 March 2018
Source:Cell Stem Cell, Volume 22, Issue 3
Author(s): Paul E. Bourgine, Ivan Martin, Timm Schroeder
Recent advances in engineering complex organs in vitro inspire the development of human bone marrow equivalents to foster scientific discovery and innovative therapeutics. Here, we discuss challenges in generating relevant human bone marrow proxies, potential design principles, and future directions.

Teaser

Recent advances in engineering complex organs in vitro inspire the development of human bone marrow equivalents to foster scientific discovery and innovative therapeutics. Here, we discuss challenges in generating relevant human bone marrow proxies, potential design principles, and future directions.


https://ift.tt/2oK86PC

Evolving Industry Partnerships and Investments in Cell and Gene Therapies

Publication date: Available online 12 April 2018
Source:Cell Stem Cell
Author(s): Devyn M. Smith, Emily J. Culme-Seymour, Chris Mason
Cell and gene therapies hold the promise of providing significant and durable health gains to patients in many disease states and have recently elicited significant investor and partner interest. We cover the current state of industry partnerships and investments, highlight what makes a partnership advantageous, and discuss implications for stem cell therapies.

Teaser

Cell and gene therapies hold the promise of providing significant and durable health gains to patients in many disease states and have recently elicited significant investor and partner interest. We cover the current state of industry partnerships and investments, highlight what makes a partnership advantageous, and discuss implications for stem cell therapies.


https://ift.tt/2IRgYeN

CD157 Marks Tissue-Resident Endothelial Stem Cells with Homeostatic and Regenerative Properties

Publication date: 1 March 2018
Source:Cell Stem Cell, Volume 22, Issue 3
Author(s): Taku Wakabayashi, Hisamichi Naito, Jun-ichi Suehiro, Yang Lin, Hideya Kawaji, Tomohiro Iba, Tsukasa Kouno, Sachi Ishikawa-Kato, Masaaki Furuno, Kazuhiro Takara, Fumitaka Muramatsu, Jia Weizhen, Hiroyasu Kidoya, Katsuhiko Ishihara, Yoshihide Hayashizaki, Kohji Nishida, Mervin C. Yoder, Nobuyuki Takakura
The generation of new blood vessels via angiogenesis is critical for meeting tissue oxygen demands. A role for adult stem cells in this process remains unclear. Here, we identified CD157 (bst1, bone marrow stromal antigen 1) as a marker of tissue-resident vascular endothelial stem cells (VESCs) in large arteries and veins of numerous mouse organs. Single CD157+ VESCs form colonies in vitro and generate donor-derived portal vein, sinusoids, and central vein endothelial cells upon transplantation in the liver. In response to injury, VESCs expand and regenerate entire vasculature structures, supporting the existence of an endothelial hierarchy within blood vessels. Genetic lineage tracing revealed that VESCs maintain large vessels and sinusoids in the normal liver for more than a year, and transplantation of VESCs rescued bleeding phenotypes in a mouse model of hemophilia. Our findings show that tissue-resident VESCs display self-renewal capacity and that vascular regeneration potential exists in peripheral blood vessels.

Graphical abstract

image

Teaser

Whether tissue-resident vascular endothelial stem cells (VESCs) exist has remained unclear. The present study demonstrates that CD157 marks vessel-resident VESCs in mouse organs that are capable of clonal expansion, angiogenesis initiation, and blood vessel maintenance. These findings represent a paradigm shift in understanding endothelial cell hierarchy within the blood vessels.


https://ift.tt/2HX5Ygv

Αναζήτηση αυτού του ιστολογίου